Upload Avatar (500 x 500)
Hu Zheng
huzheng1998@163.com
Chinese, English
Hubei
Wuhan University
Medical School
  • 2009-09 to 2012-06 - PhD in Gynecology, Huazhong University of Science and Technology
  • 2006-09 to 2009-06 - Master's in Urology, Huazhong University of Science and Technology
  • 2001-09 to 2006-06 - Bachelor in Clinical Medicine, Huazhong University of Science and Technology
  • 2022-12 to present - Vice President, Professor, Chief Physician at Central South Hospital of Wuhan University
  • 2016-04 to 2022-12 - Researcher at the First Affiliated Hospital of Sun Yat-sen University
  • 2013-12 to 2016-04 - Attending Physician at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • 2012-07 to 2013-12 - Resident Physician at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
  • 2019 - First Prize, National Maternal and Child Health Science and Technology Award
  • 2020 - First Prize, Chinese Medical Science and Technology Award
  • 2020 - Second Prize, Guangdong University Achievement Roadshow Competition
  • 2020 - Excellence Award, First China Health and Longevity Innovation Competition
HPV integration in cervical cancer
Mechanisms of HPV integration and pathophysiology in cervical cancer
Design of molecular editing techniques targeting HPV oncogenes
  • Massively parallel CRISPR off-target detection enables rapid off-target prediction model building, Hu, Z.*, 2023
  • HPV integration generates a cellular super-enhancer which functions as ecDNA to regulate genome-wide transcription, Hu, Z.*, 2023
  • FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity, Hu, Z.*, 2022
  • A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer, Hu, Z.*, 2021
  • Hyperbranched poly(β-amino ester) based polyplex nanoparticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer, Hu, Z.*, 2020
Hpv Cervical Cancer Genome Integration Pathophysiology Molecular Editing Crispr Oncogenes Cancer Therapy Gene Targeting Precision Medicine

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.